Backed by proven technology and knowledgeable and experienced management, Theralase has developed a solid business strategy with ambitious yet achievable objectives.
Business Objectives
- Expansion into US market
- Launch of TLC-2000 Biofeedback Therapeutic Laser
- Commence TLC-3000 and PDC small animal in vivo pre-clinical trial for cancer
Growth Strategy
There are a number of US market segments that provide substantial potential for growth, which include:- MDs (950,000)
- Dentists (180,000)
- Physical Therapists (150,000)
- Chiropractors (75,000)
- Veterinarians (70,000)
- Athletic Therapists (20,000)
- Sports/University Organizations (5,000)
Theralase has identified a number of activities to maximize potential growth in 2011 and beyond.
- Expansion of Direct Sales Team (in five largest states - CA, NY, FL, TX, IL)
- Seminar Series (major US cities)
- Speaking Engagement Trade Shows
- Customer Referral Program
- Partnerships with Medical and Chiropractic Colleges
- Theralase Certified Laser Centers (five largest states)



